Pharmacokinetics of desmopressin administered as tablet and oral lyophilisate formulation in children with monosymptomatic nocturnal enuresis
- 30 August 2013
- journal article
- research article
- Published by Springer Nature in European Journal of Pediatrics
- Vol. 173 (2) , 223-228
Abstract
Desmopressin 120 μg oral lyophilisate and 200 μg tablet are considered bioequivalent, based on extrapolation of studies in a limited number of adults and on one dose-finding study of desmopressin oral lyophilisate in children. However, no comparative pharmacokinetic study in children was executed confirming this statement. No data are available on the influence of food intake on the bioavailability of desmopressin tablet in a pediatric setting, although studies in adults have documented that food intake results in a significantly lower desmopressin plasma concentration. In this study, we analyzed plasma concentrations of desmopressin oral lyophilisate and tablet with concomitant food intake. Twenty-three children with monosymptomatic nocturnal enuresis (mean age, 12.7 years) were recruited. Two tests were performed on two separate days in identical conditions with a standardized food and fluid intake. Desmopressin was administered as desmopressin tablet or desmopressin oral lyophilisate immediately after a meal. Desmopressin plasma concentration was measured at 1 h, 2 h, and 6 h postdosing. No significant difference in plasma concentration of 120 μg desmopressin oral lyophilisate and 200 μg tablet was demonstrated, even with concomitant food intake. A significant difference in variability was found, identifying a smaller variance for desmopressin oral lyophilisate plasma concentrations at all time points. This study demonstrates comparable plasma levels for desmopressin oral lyophilisate, despite the lower dose. The dosage for desmopressin oral lyophilisate is more predictable due to the significantly smaller variance. Therefore, desmopressin oral lyophilisate seems more suitable, especially in the younger age group for which time interval between dinner and drug administration is limited.Keywords
This publication has 18 references indexed in Scilit:
- Oral Lyophylizate Formulation of Desmopressin: Superior Pharmacodynamics Compared to Tablet Due to Low Food InteractionJournal of Urology, 2011
- Is There Still a Role for Desmopressin in Children with Primary Monosymptomatic Nocturnal Enuresis?Drug Safety, 2010
- The role of population PK–PD modelling in paediatric clinical researchEuropean Journal of Clinical Pharmacology, 2010
- Pharmacokinetics of Desmopressin Administrated as an Oral Lyophilisate Dosage Form in Children With Primary Nocturnal Enuresis and Healthy AdultsThe Journal of Clinical Pharmacology, 2006
- Desmopressin Toxicity Due to Prolonged Half-Life in 18 Patients With Nocturnal EnuresisJournal of Urology, 2006
- A new fast‐melting oral formulation of desmopressin: a pharmacodynamic study in children with primary nocturnal enuresisBJU International, 2006
- Desmopressin for nocturnal enuresis in childrenCochrane Database of Systematic Reviews, 2002
- THE EFFICACY AND SAFETY OF ORAL DESMOPRESSIN IN CHILDREN WITH PRIMARY NOCTURNAL ENURESISJournal of Urology, 2001
- Diabetes insipidusArchives of Disease in Childhood, 1998
- Effect of food intake on the pharmacokinetics and antidiuretic activity of oral desmopressin (DDAVP) in hydrated normal subjectsClinical Endocrinology, 1998